Cancer Treatment Centers Of America Makes Headlines With Innovative Program For Cancer Patients

The Cancer Treatment Centers of America is making headlines again this year. The organization was recently headlined in an article that was published on PRNewsire.com. The article was published in February. It discusses the latest program the hospital is using to help streamline cancer treatment processes.

The program is called Clinical Pathways. It is an unique program that helps to streamline all the available data for the various types of cancer treatments available for patients. This program will allow oncologists to help patients choose the appropriate course of treatments for their individual case. The program will give patients the various treatments available and a comparison so they can make an informed decision.

The Cancer Treatment Centers of America teamed up with two other companies to create, and produce, this leading edge, interactive, program. The companies that were involved with this project were Allscripts and NantHealth, Inc. Allscripts is a leader in healthcare information technological solutions for clinical, financial, and operational departments. NantHealth, Inc., is part of the NantWorks family of organizations. The company provides scientific based, personalized healthcare to hospital patients.

It is no wonder that the CTCA is the first group of hospitals in the United States to use this type of interactive program. The CTCA was founded in the late 1980s by Richard J. Stephenson, who had lost his own mother to cancer. The goal of this organization has always been to offer cancer patients the latest and best treatment options available.

The CTCA has earned many accreditation and awards in the last 30 years since its inception. These include 5 star quality ratings by US Centers for Medicare and Medicaid Services, Top Performer on Key Quality Measures, and National Accreditation Program for Breast Cancers. The Cancer Treatment Center Of America operates five hospitals across the United States.

Leave a Reply